Literature DB >> 25643438

Survival advantages of excess body mass index in patients with idiopathic pulmonary arterial hypertension.

En-Ci Hu, Jian-Guo He, Zhi-Hong Liu, Xin-Hai Ni, Ya-Guo Zheng, Qing Gu, Zhi-Hui Zhao, Chang-Ming Xiong.   

Abstract

OBJECTIVE: An obesity paradox, a "paradoxical" decrease in morbidity and mortality with increasing body mass index (BMI), has been shown in patients with heart failure. However, the impact of BMI in patients with idiopathic pulmonary arterial hypertension (IPAH) has not been studied. This study aims to find out whether BMI is a prognostic factor in IPAH. METHODS AND
RESULTS: We analysed 173 patients with IPAH. The patients were subclassified into categories of BMI defined as: under-weight (< 18.5 kg/m2), normal weight (18.5 to 24.9 kg/m2), overweight and obese (25 to 34.9 kg/m2). The three BMI groups had similar profiles in terms of haemodynamic parameters assessed by right heart catheterization and level of NT-proBNP. The overweight and obese group had higher age, and lower WHO functional class, larger left ventricular end-diastolic dimensions (LVEDDs) than the other two groups.The Kaplan-Meier survival curves for the three BMI categories demonstrated that the overweight and obese group had a significantly higher survival rate than the normal weight and underweight groups (log-rank test, P = 0.027, P = 0.000, respectively). In a stepwise forward regression, lower BMI, higher WHO functional class, lower cardiac index, smaller LVEDDs and absence of targeted medication remained independent predictors of mortality.
CONCLUSIONS: Excess body mass is a protective factor for death in patients with IPAH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25643438     DOI: 10.1080/ac.69.6.1000010

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  6 in total

1.  Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registry.

Authors:  S Mazimba; E Holland; V Nagarajan; A D Mihalek; J L W Kennedy; K C Bilchick
Journal:  Int J Obes (Lond)       Date:  2017-02-17       Impact factor: 5.095

2.  Association of nutritional status and mortality risk in patients with primary pulmonary hypertension.

Authors:  Dongling Luo; Nanshan Xie; Ziyang Yang; Caojin Zhang
Journal:  Pulm Circ       Date:  2022-01-12       Impact factor: 2.886

3.  The obesity paradox in pulmonary arterial hypertension: the Scottish perspective.

Authors:  Luke Lawson McLean; Katherine Pellino; Melanie Brewis; Andrew Peacock; Martin Johnson; Alistair Colin Church
Journal:  ERJ Open Res       Date:  2019-11-25

4.  BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis.

Authors:  Breanne E McCarthy; Robyn L McClelland; Dina H Appleby; Jude S Moutchia; Jasleen K Minhas; Jeff Min; Jeremy A Mazurek; K Akaya Smith; Jason S Fritz; Steven C Pugliese; Ryan J Urbanowicz; John H Holmes; Harold I Palevsky; Steven M Kawut; Nadine Al-Naamani
Journal:  Chest       Date:  2022-03-03       Impact factor: 10.262

5.  Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Zhengyang Lu; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

6.  Two-dimensional speckle tracking echocardiography detected interventricular dyssynchrony predicts exercise capacity and disease severity in pre-capillary pulmonary hypertension.

Authors:  Bing-Yang Liu; Wei-Chun Wu; Qi-Xian Zeng; Zhi-Hong Liu; Li-Li Niu; Yue Tian; Xiao-Ling Cheng; Qin Luo; Zhi-Hui Zhao; Li Huang; Hao Wang; Jian-Guo He; Chang-Ming Xiong
Journal:  Ann Transl Med       Date:  2020-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.